Bausch + Lomb Corporation (BLCO)
NYSE: BLCO · Real-Time Price · USD
15.55
+0.02 (0.13%)
Nov 7, 2025, 4:00 PM EST - Market closed
Bausch + Lomb Revenue
Bausch + Lomb had revenue of $1.28B in the quarter ending September 30, 2025, with 7.11% growth. This brings the company's revenue in the last twelve months to $4.98B, up 6.23% year-over-year. In the year 2024, Bausch + Lomb had annual revenue of $4.79B with 15.56% growth.
Revenue (ttm)
$4.98B
Revenue Growth
+6.23%
P/S Ratio
1.10
Revenue / Employee
$368,593
Employees
13,500
Market Cap
5.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.79B | 645.00M | 15.56% |
| Dec 31, 2023 | 4.15B | 378.00M | 10.03% |
| Dec 31, 2022 | 3.77B | 3.00M | 0.08% |
| Dec 31, 2021 | 3.77B | 353.00M | 10.35% |
| Dec 31, 2020 | 3.41B | -366.00M | -9.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
BLCO News
- 10 days ago - Bausch + Lomb Corporation (BLCO) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Bausch + Lomb Announces Third-Quarter 2025 Results - Business Wire
- 19 days ago - Activist Jana Takes Stake in Cooper, a Maker of Medical Devices - WSJ
- 5 weeks ago - Bausch + Lomb Will Release Third-Quarter 2025 Financial Results on Oct. 29 and Hold Investor Day on Nov. 13 - Business Wire
- 2 months ago - Bausch + Lomb Corporation (BLCO) Bausch + Lomb Corporation Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 2 months ago - Bausch + Lomb Launches ASANA™ Gas Permeable Lenses in the United States - Business Wire
- 2 months ago - Bausch + Lomb Announces Board Changes - Business Wire
- 3 months ago - Bausch + Lomb to Participate in Upcoming Investor Conferences - Business Wire